Eplerenone MYLAN 25 mg is a medication containing eplerenone supplied as film-coated tablets. The product is commonly used in cardiology and included in comprehensive cardiovascular therapy programs.
The medication belongs to the class of selective aldosterone antagonists and is intended for use under medical supervision. Eplerenone MYLAN supports cardiovascular management in conditions associated with aldosterone activity.
The product is available in two package sizes:
Eplerenone MYLAN 25 mg may be prescribed in cases involving:
The medication should only be used according to healthcare professional recommendations.
Eplerenone is a selective mineralocorticoid receptor antagonist. The active ingredient is used to support cardiovascular function and help manage conditions associated with aldosterone effects.
The medication is widely used in cardiology treatment programs.
The tablets should be taken orally according to medical advice.
Dosage and treatment duration are determined individually based on patient condition.
The tablets should be swallowed whole with water.
У некоторых пациентов могут наблюдаться:
Medical attention should be sought if adverse effects occur.
The medication should not be used in patients with hypersensitivity to eplerenone or any formulation components.
Consultation with a healthcare professional is recommended before use, especially in patients with kidney, liver, or cardiovascular conditions.
Eplerenone MYLAN is a cardiovascular medication containing eplerenone.
Eplerenone is commonly used in cardiovascular conditions associated with aldosterone activity.
The medication should be taken orally according to healthcare professional instructions.
Treatment duration should always be determined by a physician.
Doctors may recommend monitoring potassium levels and kidney function during therapy.
Задайте вопрос или уточните условия доставки в вашу страну